First-line durvalumab plus platinum–etoposide in Japanese patients with extensive-stage small-cell lung cancer by Eisuke Mochizuki, Shun Matsuura, Naoki Koshimizu, Suguru Kojima, Shogo Sakurai, Satoshi Kishimoto, Mitsuru Niwa, Masayuki Watanuki, Ryunosuke Inaba, Sho Takuma, Yusuke Inoue, Masato Karayama, Naoki Inui, Takafumi Suda

Get full text

Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cells by Hirofumi Watanabe, Yusuke Inoue, Kazuo Tsuchiya, Kazuhiro Asada, Makoto Suzuki, Hiroshi Ogawa, Masayuki Tanahashi, Takuya Watanabe, Shun Matsuura, Kazuyo Yasuda, Ippei Ohnishi, Shiro Imokawa, Hideki Yasui, Masato Karayama, Yuzo Suzuki, Hironao Hozumi, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Kazuhito Funai, Kazuya Shinmura, Haruhiko Sugimura, Naoki Inui, Takafumi Suda

Get full text

Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies by Yusuke Inoue, MD, PhD, Yoshihiro Kitahara, MD, Masato Karayama, MD, PhD, Kazuhiro Asada, MD, PhD, Koji Nishimoto, MD, PhD, Shun Matsuura, MD, PhD, Dai Hashimoto, MD, PhD, Masato Fujii, MD, PhD, Takashi Matsui, MD, PhD, Nao Inami, MD, Mikio Toyoshima, MD, PhD, Hiroyuki Matsuda, MD, PhD, Masaki Ikeda, MD, PhD, Mitsuru Niwa, MD, PhD, Yusuke Kaida, MD, PhD, Masaki Sato, MD, PhD, Yasuhiro Ito, MD, Hideki Yasui, MD, PhD, Yuzo Suzuki, MD, PhD, Hironao Hozumi, MD, PhD, Kazuki Furuhashi, MD, PhD, Noriyuki Enomoto, MD, PhD, Tomoyuki Fujisawa, MD, PhD, Naoki Inui, MD, PhD, Takafumi Suda, MD, PhD

Get full text